Alembic Ltd's Q3FY25 Quarter Results
- 08 Feb 2025
Result Summary
- Alembic Ltd reported a 47.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 49.9%.
- Its expenses for the quarter were down by 4.9% QoQ and up 13.8% YoY.
- The net profit decreased 46.0% QoQ and increased 6.5% YoY.
- The earnings per share (EPS) of Alembic Ltd stood at 2.5 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 62.29 | 118.52 | 41.55 | -47.4% | 49.9% |
Total Expenses | 34.90 | 36.68 | 30.67 | -4.9% | 13.8% |
Profit Before Tax | 27.39 | 81.83 | 10.88 | -66.5% | 151.7% |
Tax | 1.30 | 4.51 | 0.96 | -71.2% | 35.4% |
Profit After Tax | 65.39 | 121.02 | 61.42 | -46.0% | 6.5% |
Earnings Per Share | 2.50 | 4.70 | 2.40 | -46.8% | 4.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Alembic Ltd is a well-established company primarily operating in the pharmaceutical industry. The company is known for its wide range of products, including formulations, active pharmaceutical ingredients (APIs), and generics. Alembic has a significant presence in both domestic and international markets, with a focus on research and development to innovate and expand its product offerings. While specific recent developments are not available within this dataset, Alembic has historically been involved in expanding its reach through strategic partnerships and increasing its manufacturing capabilities to meet global demand.
Revenue
In the third quarter of the fiscal year 2025 (Q3FY25), Alembic Ltd reported a total income of ₹62.29 crores. This represents a notable decrease of 47.4% from the previous quarter (Q2FY25), where the total income was ₹118.52 crores. However, when compared to the same quarter in the previous fiscal year (Q3FY24), the total income shows a significant increase of 49.9%, rising from ₹41.55 crores. These figures highlight the variability in revenue generation on a quarterly basis while demonstrating a positive year-over-year growth trend.
Profitability
The profitability metrics for Alembic Ltd display a dynamic picture. The company recorded a profit before tax of ₹27.39 crores in Q3FY25, which marks a substantial decline of 66.5% from Q2FY25, where the profit was ₹81.83 crores. Despite the quarter-over-quarter decrease, the year-over-year comparison with Q3FY24 shows a dramatic increase of 151.7%, as the profit before tax in that period was ₹10.88 crores. The profit after tax in Q3FY25 is ₹65.39 crores, down 46.0% from ₹121.02 crores in Q2FY25, but up 6.5% compared to ₹61.42 crores in Q3FY24. These changes are reflected in the earnings per share, which decreased to ₹2.50 in Q3FY25 from ₹4.70 in Q2FY25, a decline of 46.8%, yet showing a modest increase of 4.2% from ₹2.40 in Q3FY24.
Operating Metrics
Alembic Ltd's operating expenses were reported at ₹34.90 crores in Q3FY25, showing a slight decline of 4.9% from the previous quarter's expenses of ₹36.68 crores. When compared to the same quarter the previous year, there is an increase of 13.8% from ₹30.67 crores in Q3FY24. The tax expense for Q3FY25 was ₹1.30 crores, a significant reduction of 71.2% from Q2FY25, where it was ₹4.51 crores, and an increase of 35.4% from the ₹0.96 crores reported in Q3FY24. These operating metrics provide a snapshot of the company's management of expenses and tax liabilities over the periods in question.
